We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Serum and Synovial Uric Acid Validated as Markers for Osteoarthritis

By LabMedica International staff writers
Posted on 02 Feb 2011
The amount of uric acid in the synovial fluid of the knee is strongly correlated with the severity of osteoarthritis and the progression of the disease over time. More...


The amount of uric acid in both serum and synovial fluid can be estimated using high performance liquid chromatography (HPLC) and correlated with the severity of debilitating joint degeneration found in patients with osteoarthritis (OA).

A study carried out at Duke University Medical Center (Durham, NC, USA) examined 159 (118 females, 41 males) patients, who had knee osteoarthritis but no history of gout, a type of arthritis triggered by uric acid crystals in the joints. A total of 138 participants returned for follow-up three years later to assess progression of knee OA. The study was conducted from January 2003 until March 2008. Serum and knee synovial fluid samples were obtained within 10 minutes of each other after a two hour fast in the mid-afternoon. The synovial fluid analyses were limited to 69 study participants (49 women and 20 men) with sufficient synovial fluid volumes for uric acid analyses.

Although this cohort was recruited based on knee OA and absence of gout history, a surprising 39% of this cohort had serum uric acid concentrations above their respective reference ranges of 7.2 mg/dL for men and 6.0 mg/dL for women. Uric acid was quantified in both knees of 63 participants and single knees of 6 participants, and their paired sera. The mean serum uric acid concentrations were significantly higher than their paired synovial fluid uric acid concentrations. Of the 132 synovial fluid samples, matched serum exceeded synovial fluid uric acid concentrations for 113 (85.6%), whereas only 19 (14.4%) had greater synovial fluid than serum uric acid concentrations.

Virginia Byers Kraus, MD, PhD, professor of medicine at Duke University, said, "We've always thought of uric acid as the agent for gout, but it may be a much more general agent. In a non-gout population, this provides some of the very first evidence that uric acid level is a potential cause of inflammatory events and joint degeneration in osteoarthritis.” The study was accepted for publication on December 10, 2010, in the Proceeding of the [US] National Academy of Science of the United States, (PNAS).

Related Links:

Duke University Medical Center




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.